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Background: The epidemiologic profile of ethnic Chinese patients with Dupuytren’s disease is unknown. We therefore
investigated the epidemiology of Dupuytren’s disease using Taiwan’s National Health Insurance Research Database.
Methods: Patients who filed claims for treatment for Dupuytren’s disease between January 2000 and December 2011
were identified in the database. Age- and gender-specific incidences were estimated by dividing the incidence number
by population data.
Results: We identified 1,078 patients with Dupuytren’s disease (681 men, 397 women; male/female ratio: 1:1.72). The
annual incidence rate ranged from 0.39-0.63/105 for men and 0.14-0.44/105 for women. A trend analysis revealed a rising
trend in the annual incidence from 2001 to 2011 (p = 0.0199). The prevalence rate increased steadily from 0.46/105 in
2000 to 4.52/105 in 2011 (p = 0.0186). The mean age at onset was significantly higher in men than in women
(60.7 ± 18.4 vs. 53.7 ± 15.5 years). Peak age at onset for men was 70–79 (28.1%) and for women was 50–59 (33.5%).
Men > 60 years old had higher incidence rates than did women (incidence rate ratios: 2.0, 4.5, and 6.6 for those 60–69,
70–79, and ≥ 80, respectively). Hypertension (29.6%), diabetes mellitus (21.9%), hyperlipidemia (14.8%), ischemic heart
disease (10.5%), and chronic obstructive pulmonary disease (8.0%) were the most common comorbidities.
Conclusions: The incidence and prevalence of Dupuytren’s disease and the male/female ratio were significantly lower
in ethnic Chinese than in Western ethnic groups. Moreover, the age at onset was significantly lower in ethnic Chinese
women. However, the incidences of three comorbidities (hypertension, diabetes mellitus, and hyperlipidemia) were
similar to those in other ethnicities.
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Dupuytren’s disease (DD), also called Dupuytren’s con-
tracture or palmar fibromatosis, is a common and often
irreversible and progressive fibroproliferative tissue con-
traction affecting the palmar fascia [1]. Its typical diag-
nostic features are the presence of a nodule and the
subsequent formation of a contracture cord. The con-
tracture usually begins in the palm and then progresses* Correspondence: chinchen.chu@gmail.com
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unless otherwise stated.distally, which results in finger flexion contracture. Nod-
ules can present in both the palm and fingers. The ring
finger is most often affected, and then, in order of fre-
quency, the small finger, thumb, middle finger, and index
finger [2]. DD is commonly bilateral, and it can become
both a physically and a psychosocially disabling condi-
tion that significantly affects healthcare resources [3].
The etiology of DD is still not clear. Clinical studies
show that it is strongly associated with genetic, geo-
graphic, and environmental factors [4]. DD has also been
linked to many risk factors, including a history of smok-
ing [5], alcohol consumption [6], frozen shoulder [7],
epilepsy [8], diabetes mellitus [9], carpal tunnel syn-
drome [10], and hand injury [11].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lence of DD occurs in white northern Europeans. Trad-
ition has it that the disease originated with the Vikings,
who spread it throughout northern Europe and beyond
as they traveled and intermarried [12]. DD is often called
the “Viking” or “Nordic” disease. It is reported to be
present in 46% of the population of Norway, 39% of
Scotland, 33% of Iceland, and 32% of Finland [13-15]. It
is one of the most commonly inherited connective tissue
disorders in Norwegians > 60 years old [16]. Neverthe-
less, the disease does occur in nearly all populations
[3,17-24]. The prevalence of Dupuytren's disease is
0.53% (533 per 105) in Hispanics in the USA [23], 28%
in Australia [15], 3% in the USA, and > 4% in the male
population in England [25]. DD is believed to be rare in
Asians. In ethnic Chinese in particular, it is usually de-
scribed as a sporadic finding, and the epidemiological re-
ports on DD in Asians are limited to small case series
reports [19,26]. In a population study in the USA, the
prevalence of DD in Asians in one New York City hos-
pital was 0.28% [23]. Given that the prevalence of DD
varies greatly based on genetics, geography, and environ-
ment [8], the epidemiological data from other countries
cannot be applied to ethnic Chinese. Therefore, using a
nationwide database in Taiwan, we investigated the epi-
demiological profiles of DD in ethnic Chinese in Taiwan.
Our findings should provide a better understanding of
the reported epidemiological trends and comorbid fac-
tors of DD in ethnic Chinese.
Methods
Database
Population-based data were obtained from the reim-
bursement claims database of Taiwan’s National Health
Insurance (NHI). The NHI program began in Taiwan in
1995 and the NHI database contains annually updated
information from 1997 to the present. All medical bene-
fit claims for more than 99% of Taiwan’s 23 million legal
residents (citizens and noncitizens) are included. The
NHI Research Database (NHIRD) provides encrypted
patient identification numbers, gender, date of birth,
dates of admission and discharge, ICD-9-CM diagnosis
and procedure codes (up to 5 each), details of prescrip-
tions, and costs covered and paid for by the NHI. The
NHI Bureau approved our use of these data, and Chi
Mei Medical Center hospital institutional review board
approval was waived for this study because patient infor-
mation was encrypted.
Patients and variables
Patients with DD were identified either from ambulatory
visits or from inpatient claims using the ICD-9-CM diag-
nosis code 728.6. We also recorded respiratory, cardiac,
renal, cerebrovascular, and gastrointestinal comorbidities.We counted these as comorbidities if the condition oc-
curred either in inpatient claims or in 2 or more outpatient
claims coded 12 months before and after the index medical
care date for DD.
Outpatient claim files include an encrypted personal
identification number, date of birth, date of service, rele-
vant department, expenses, and the first 3 ICD-9 codes.
Hospitalization discharge claims include an encrypted
personal identification number, date of birth, length of
stay, relevant department, expenses, and the first 5
ICD-9 codes. Multiple outpatient and hospitalization
discharge claims with the same encrypted personal
identification number were counted once so that only the
incidence of the disease was counted. The prevalence was
calculated by dividing the number of total cases for each
year by the corresponding total population.
Average age- and gender-specific incidence rates were
calculated by dividing the number of new cases in each
age and gender group by the age- and gender-specific
population, and then averaging these data from 2001 to
2011. Detailed age-specific population information for
Taiwan used to calculate age-specific incidences in this
study is from the Taiwan Ministry of the Interior, Executive
Yuan (http://www.moi.gov.tw/stat/english/year.asp).
The communities in Taiwan were stratified into 7
urbanization categories according to the standards pub-
lished by the Taiwanese National Health Research Insti-
tute (NHRI): code 1 =most urbanized and code 7 = least
urbanized. These standards include the population density
(people/km2), the ratio of people with high educational
levels (college or above), the ratio of people ≥ 65 years old,
the ratio of agricultural workers, and the number of physi-
cians per 100,000 people [27].
Statistical analysis
SAS 9.3 for Windows (SAS Institute, Cary, NC, USA)
was used for this study. Student's t test was used to
compare continuous variables (age differences between
men and women). The incidence rate ratio was esti-
mated using Poisson regression. For categorical vari-
ables, a two-tailed Fisher's Exact test was used for < 5
cases (rheumatologic disease, pulmonary tuberculosis,
valvular heart disease, and alcoholism) and Pearson's χ2
test for > 5 cases (hypertension, diabetes mellitus, hyper-
lipidemia, ischemic heart disease, chronic obstructive
pulmonary disease [COPD], stroke, cancer, hepatitis, and
chronic renal failure level of urbanization, and hospital
location). The Mantel-Haenszel extension of the χ2 test
was used for trend analysis. Significance was set at p < 0.05.
Results
We identified 1078 cases of DD in the NHIRD (103 ex-
tant cases in 2000 and 975 new cases during 2001–2011;
681 men and 397 women) (Table 1). The annual incidence
Table 1 Incidence and prevalence of Dupuytren’s disease in Taiwan by gender
Total population × 106 New cases Total cases Incidence rate per 105/year Prevalence per 105 M/F ratio of
incidence
Year M/F Total M/F Total M/F Total M/F Total M/F Total
2000 11.4/10.9 22.3 67/36 103 0.59/0.33 0.46 1.78
2001 11.4/11.0 22.4 54/15 69 121/51 172 0.47/0.14 0.31 1.06/0.46 0.77 3.47
2002 11.5/11.0 22.5 57/25 82 178/76 254 0.50/0.23 0.36 1.55/0.69 1.13 2.18
2003 11.5/11.1 22.6 47/29 76 229/105 329 0.41/0.26 0.34 1.95/0.95 1.46 1.56
2004 11.5/11.1 22.7 45/35 80 269/140 409 0.39/0.32 0.35 2.34/1.26 1.86 1.24
2005 11.6/11.2 22.8 48/31 79 314/171 485 0.41/0.28 0.35 2.71/1.53 2.13 1.49
2006 11.6/11.3 22.9 49/27 76 363/198 561 0.42/0.24 0.33 3.13/1.75 2.45 1.77
2007 11.6/11.3 23.0 61/23 84 423/220 643 0.53/0.20 0.37 3.65/1.95 2.80 2.58
2008 11.6/11.4 23.0 56/44 100 475/263 738 0.48/0.39 0.43 4.09/2.31 3.21 1.25
2009 11.6/11.5 23.1 73/39 112 545/300 845 0.63/0.34 0.48 4.70/2.61 3.66 1.86
2010 11.6/11.5 23.2 67/42 109 607/342 949 0.58/0.37 0.47 5.23/2.97 4.09 1.58
2011 11.6/11.6 23.2 57/51 108 655/393 1048 0.49/0.44 0.47 5.65/3.39 4.52 1.12
Total new cases 614/361 975
Total identified cases: 681/397 1078 1.72
(new cases from 2001–2011 + extant cases in year 2000)
M/F, male/female.
The data of total population are from the Directorate General of the Budget, Accounting, and Statistics, Executive Yuan, Taiwan. (http://www.moi.gov.tw/stat/
english/year.asp).
Trend analysis 2001–2011: for incidence rate p = 0.0199 and for prevalence rate p = 0.0186 (Mantel-Haenszel extension of the χ2 test).
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for women. A trend analysis revealed a rising trend in the
annual incidence from 2001 to 2011 (p = 0.0199). The inci-
dence rate for men was always higher than for women
(average M/F incidence ratio: 1.72 during 2001–2011). The
prevalence rate increased steadily from 0.46/105 in 2000 to
4.52/105 in 2011 (p = 0.0186). The prevalence in 2011 was
5.65/105 for men and 3.39/105 for women. Confidence in-
tervals (CIs) are not reported because these are national
population data, not a sample.
The mean age of patients with DD was significantly
higher in men (60.7 ± 18.4 years) than in women
(53.7 ± 15.5) (Table 2). The incidence was lowest in
the < 40 age group and higher in the older age groups
for both genders. The highest incidences were in 70- to 79-
year-old men (28.1%) and 50- to 59-year-old women
(33.5%). The difference was significantly higher in 60- to
69-, 70- to 79-, and ≥ 80-year-old men than in women in
those age groups.
The most common comorbidities for these 1,078 pa-
tients were hypertension (319; 29.6%), diabetes mellitus
(236; 21.9%), hyperlipidemia (159; 14.8%), ischemic heart
disease (113; 10.5%), and COPD (86; 8.0%) (Table 3).
Significantly more men had hypertension (p < 0.001), is-
chemic heart disease (p = 0.0167), and COPD (p < 0.001)
than did women. There were no significant differences
between where the hospitals were or the degree of
urbanization between men and women.Discussion
This is not only the first population-based epidemio-
logical study on DD in Taiwan, but it is also is the lar-
gest epidemiological study that has ever been conducted
on DD in an Asian country, and one of very few that
uses as its source one nation’s entire stock of national
health insurance claims data. Because of the low inci-
dence, it is difficult and impractical to field community
studies for an epidemiological approach. The NHIRD,
however, is a prodigious resource for studying the epi-
demiology of rare diseases like DD. We found that both
the incidence and prevalence rates of DD are much
lower for ethnic Chinese in Taiwan than for Europeans
[14,28,29] and US Americans [24,30]. However, the an-
nual incidence rate of DD in Taiwan increased during
the study period, especially for women. We also found
that the most common comorbidities in ethnic Chinese
DD patients were hypertension, diabetes mellitus, hyper-
lipidemia, ischemic heart disease, and COPD.
Other studies’ estimated prevalence rates of DD
ranged from 0.2% [31] to 56% [32]; the large range is at-
tributable to variations in age, population groups, and
methods of data collection. Most of the epidemiological
data were obtained by sampling specific populations
[14,21,24,33] or by retrospectively reviewing charts [23,34].
For instance, one US study [24] estimated the prevalence
rate of DD using an online survey from an Internet-based
research panel representative of the US population, and
Table 2 Age-specific average incidence of Dupuytren’s disease in Taiwan during 2000–2011
Average incidence
Cases n (%) Total per 105/year M/F incidence
Age group (years) M (n = 681) F (n = 397) (n = 1078) M/F M F Total Rate ratio (95% CI) p
<40 83 (12.2%) 60 (15.1%) 143 (13.3%) 1.38 0.10 0.08 0.09 1.3 (0.9-1.8) 0.1069
40-49 75 (11.0%) 74 (18.6%) 149 (13.8%) 1.01 0.34 0.34 0.34 1.0 (0.7-1.4) 0.9964
50-59 118 (17.3%) 133 (33.5%) 251 (23.3%) 0.89 0.73 0.81 0.77 0.9 (0.7-1.2) 0.3992
60-69 149 (21.9%) 79 (19.9%) 228 (21.2%) 1.89 1.64 0.81 1.21 2.0 (1.5-2.6) <0.0001
70-79 191 (28.1%) 41 (10.3%) 232 (21.5%) 4.65 2.94 0.65 1.81 4.5 (3.3-6.2) <0.0001
≥80 65 (9.5%) 10 (12.2%) 75 (2.5%) 6.50 2.37 0.36 1.36 6.6 (3.7-11.7) <0.0001
Age (mean ± SD) 60.7 ± 18.4 53.7 ± 15.5 <0.0001
M, male; F, female.
Data are n (%) unless otherwise indicated.
Table 3 Gender-specific comorbidities, urbanization, and hospital level for 1078 patients with Dupuytren’s disease
in Taiwan
Variables Total = 1078 (100%) Male = 681 (100%) Female = 397 (100%) *p
Comorbidities (n (%))
Hypertension 319 (29.6) 231 (33.9) 88 (22.2) <0.0001$
Diabetes mellitus 236 (21. 9) 163 (23.9) 73 (18.4) 0.0336$
Hyperlipidemia 159 (14.8) 95 (14.0) 64 (16.1) 0.3323$
Ischemic heart disease 113 (10.5) 83 (12.2) 30 (7. 6) 0.0167$
COPD 86 (8.0) 74 (10.9) 12 (3.0) <0.0001$
Stroke 54 (5.0) 40 (5.9) 14 (3.5) 0.0884$
Cancers 37 (3.4) 26 (3.8) 11 (2.8) 0.3624$
Hepatitis (B or C) 17 (1.6) 11 (1.6) 6 (1.5) 0.8949$
CKD 21 (2.0) 11 (1.6) 10 (2.5) 0.3005$
Rheumatic disease 14 (1.3) 3 (0.4) 11 (2.8) 0.0017&
Pulmonary tuberculosis 8 (0.7) 5 (0.7) 3 (0.8) 1.0000&
Valvular heart disease 7 (0.7) 5 (0.7) 2 (0.5) 0.6496&
Alcoholism 1 (0.1) 1 (0.2) 0 (0.0) 1.0000&
Urbanization 0.0980$
1 (highest) 275 (25.5) 179 (26.3) 96 (24.2)
2 567 (52.6) 366 (53.7) 201 (50.6)
3 38 (3.5) 17 (2.5) 21 (5.3)
4 171 (15.9) 101 (14.8) 70 (17.6)
≥5 27 (2.5) 18 (2.6) 9 (2.3)
Hospital location 0.4407$
1. North 579 (53.7) 375 (55.1) 204 (51.4)
2. Central 158 (14.7) 95 (14.0) 63 (15.9)
3. South 316 (29.3) 193 (28.34) 123 (31.0)
4. East 25 (2.3) 18 (2.6) 7 (1.8)
COPD: chronic obstructive pulmonary disease. CKD, chronic kidney disease.
Urbanization: level 1 indicating most urbanized and level 7 indicating least urbanized. Criteria for calculating urbanization include population density (people/km2),
ratio of people with high educational levels (college or above), the ratio of people ≥ 65 years old, the ratio of agricultural workers, and the number of physicians per
100,000 people.
*Men compared with women; &Fisher’s Exact test; $Pearson's χ2 test.
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a physician to a market. Our estimate, however, is based
not on a sampling, but on data from Taiwan’s NHIRD, into
which data are entered without a selection bias. No similar
information is available in the published literature in
Taiwan or in any other Asian country. Because the diagno-
sis of DD was already recorded using ICD-9 codes, and be-
cause each diagnosis was made by a physician rather than
being based on the patient’s memory on a health history
questionnaire, a misclassification bias is unlikely. Because
patients with only mild symptoms might not seek medical
help, and therefore will not be entered in the database, the
incidence and prevalence may be underestimated. How-
ever, DD is a proliferative and progressive disease, and
most people who have it will ultimately need medical
attention. Therefore, if the observation period is long
enough, the underestimation will become smaller. Further-
more, because more than 98% of Taiwan’s population is
ethnic Chinese [35], our data can represent the epidemio-
logical features of DD in ethnic Chinese.
The two main foci of epidemiological studies are inci-
dence rate and prevalence rate. The former is defined as
the number of new cases of a disease over a specific
time-period and the latter as the current number of
cases of disease at a single point in time. Most previous
epidemiological studies of DD that have quoted inci-
dence rates were in fact referring to prevalence rate [15].
In the present study, we identified new cases every year
from the NHIRD. The average annual incidence rate of
DD in Taiwan during 2000–2011 was only 0.39/105
(men 0.48/105; women 0.29/105), which was much lower
than that of a UK study [29] (502,493 men; annual inci-
dence: 34.3/105 men), and of a US population-based
study [24] (annual incidence: estimated at 30.0/105
adults). We found that DD in Taiwan was much less
prevalent than in Western countries [14,21,22,33]. Eth-
nic studies [14,17,21] show that DD is highly prevalent
in Scandinavians. A US veterans-hospital-based study
[30] reported that the prevalence of DD is highest in
Whites and then Hispanic Whites, Blacks, and Asians.
The epidemiological reports on DD in Asia are only
case series or else are limited to special groups. A
Taiwanese study [19] reported 41 cases of DD in Taiwan
during 1970–1988. Because it was case series from a sin-
gle hospital, neither an incidence rate nor a prevalence
rate could be reported. In addition, a Japanese cross-
sectional study [36] of 1,154 patients reported preva-
lence rates of 19.7% for men and 9% for women. Because
all the patients were more than 60 years old and lived
in nursing homes, they did not represent a general
population.
In the present study, we found a trend of rising inci-
dence and prevalence rates from 2001 to 2011. We
hypothesize that the trend is a reflection of the agingpopulation because the prevalence and severity of DD
increases with age [37]. Moreover, the incidence of DD
increases with comorbidities like diabetes mellitus [9,31],
hyperlipidemia [38,39], and hypertension [23,40], all of
which are highly prevalent in the elderly [41-44]. Fur-
thermore, the universal coverage and low copayment of
Taiwan’s NHI system has increased the affordability of
healthcare here, which increases the diagnostic rate for
DD. In addition, increased medical knowledge from the
Internet might also contribute to the higher contempor-
ary rate of medical consultation [45].
The average age at the onset of DD is about 60 years
old, and the incidence rises thereafter [13,37]. Similarly,
in our study, the onset of DD age-dependently increased
for men, and the incidence rate peaked at 2.94/105
person-years at age 70–79 and dropped a little to 2.37/105
person-years for men over 80. For women < 40 years old,
however, the incidence rate jumped from 0.08/105 to
0.81/105 person-years for those 50–69 years old, and
fell by 20% to 0.65/105 person-years for those 70–79
and then by 55% to 0.36/105 person-years for ≥ 80.
These rates are different from those reported [46,47] for
other ethnicities, in which the incidence continuously in-
creased with age in women.
Another unique epidemiology profile for DD in ethnic
Chinese is that there are no gender differences in inci-
dence rates for patients < 60, but for those ≥ 60, the inci-
dence rates increased more dramatically for men than
for women. The male:female incidence rate ratio in-
creases from 2.0 to 6.6 for those 60–69 and ≥ 80 years
old. This is quite different from reports on other ethnici-
ties in which the gender difference in the incidence rate
diminishes with increasing age; specifically; the male:fe-
male incidence rate ratio approaches 1:1 for people ≥ 80
[17,25,46,47]. Additional studies are necessary to deter-
mine the underlying mechanisms.
Generally, DD is much less common in women than
in men, with reported overall male:female incidence rate
ratios ranging from 1.7:1 to 9.5:1[37,46,47]. Similar to
what has been reported in the literature, our results
show that both the incidence and prevalence rates
are higher for men than for women in Taiwan. The
male:female incidence and prevalence rate ratios, how-
ever, are 1.72 and 1.55, which are lower than those for
Europeans and Australians [37,46], but close to that for
US Americans [47]. Additionally, a US study [46] re-
ported that women were older (mean age: 62.4 years)
at their first operation (62.4 years) than were men
(59.8 years). Other studies [14,21] also report that age at
the onset of DD is about 10 years lower in men than in
women. However, in the present study, the mean age at
onset was about 7 years lower in women (53.72 years)
than in men (60.69 years). This, however, might be attrib-
utable to genetic and environmental differences between
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logical profile report of DD in Taiwanese; thus, from our
results, no direct evidence can be drawn determine
the underlying mechanism for the early onset of DD in
Taiwanese women.
A number of epidemiologic factors have been associ-
ated with the development of DD: e.g., diabetes mellitus,
hyperlipidemia, hypertension, epilepsy, smoking, and
alcoholism [13,15,37,48]. We found that hypertension,
diabetes mellitus, and hyperlipidemia were the most
common comorbidities both in men and in women. All
of these diseases may impair microvascular circulation
and cause localized ischemia, which increases free radi-
cals and inflammatory cytokines [37], and concomitantly
alters gene expressions of growth factors, adhesion mol-
ecules, and extracellular matrix components that, in
turn, trigger the proliferation of DD tissue [49].
Our study has some limitations. First, our cohort was
identified by ICD-9 codes coded by physicians. Patients
with only mild symptoms might not seek medical care
and thus were not included in our database. Therefore,
the calculation of incidence and prevalence rates based
on the NHIRD might underestimate the true rates. Sec-
ond, data on several environmental factors believed to
contribute to DD development, including alcohol intake,
smoking, manual labor, or exposure to vibrations [37],
were not available in the NHIRD. Only one man among
our identified 1,078 patients had been diagnosed with al-
coholism; this is undoubtedly an underestimated preva-
lence rate of habitual alcohol drinking for Taiwan. Third,
although the administrative claims data allowed us to
identify patients diagnosed with DD, they did not con-
tain information about the severity of the disease.
Fourth, there were no data about blood biochemistry,
pathology reports, or finger function; thus, it was not
possible to determine whether the disease was progres-
sing or in remission. Fifth, although 98% of Taiwanese
residents are ethnic Chinese, there are residents of other
ethnicities, most of whom are aboriginal Austronesian
Taiwanese [35]. Patients’ ethnicities were not recorded in
the NHIRD; therefore, we did not know the distribution of
DD in ethnic Chinese and aborigines. However, the highest
population density of Taiwanese aborigines is in eastern
Taiwan, and DD is lowest in that area. Sixth, although the
NHI regularly investigates the quality of the ICD-9 coding
in the claims database to ensure that diagnoses in particu-
lar are accurate, we still cannot exclude the possibility that
some might be incorrect because of mistakes by the med-
ical coders and physicians responsible for entering the
codes. These limitations may compromise our findings.
Conclusions
The incidence and prevalence rates of DD in ethnic
Chinese in Taiwan were much lower than those reportedfor other ethnic groups in the rest of the world. More-
over, DD in Taiwan has an earlier onset in ethnic Chinese
women and a lower M:F incidence rate ratio. However, dia-
betes mellitus, hyperlipidemia, and hypertension, the most
common comorbidities of DD in ethnic Chinese, were
similar to those in other ethnic groups. Additional studies
are needed in order to determine, for example, whether the
underlying mechanisms are genetic, environmental, or so-
cioeconomic factors, or some combination of these.
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